PATENT CLAIM ANALYSIS

Application Number: 15882038
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["546", "157000"]

Abstract:
The disclosures herein relate to novel compounds of formula wherein Ar 1  and R 1  are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Claim (Index 11):
The method of  claim 1 , wherein the compound of formula (I) is selected from the group consisting of:\n N-[(2R)-1-[4-(1H-imidazol-2-yl)-1,4\u2032-bipiperidin-1\u2032-yl]-3-(7-methyl-1H-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide; N-[(2R)-1-[4-(4-methyl-1H-imidazol-5-yl)-1,4\u2032-bipiperidin-1\u2032-yl]-3-(7-methyl-1H-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide; N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-[4-(1-propyl-1H-imidazol-2-yl)-1,4\u2032-bipiperidin-1\u2032-yl]propan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide; N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methyl-4H-1,2,4-triazol-3-yl)-1,4\u2032-bipiperidin-1\u2032-yl]-1-oxopropan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide; 4-(7-fluoro-2-oxo-1,2-dihydroquinolin-3-yl)-N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(4-methyl-4H-1,2,4-triazol-3-yl)-1,4\u2032-bipiperidin-1\u2032-yl]-1-oxopropan-2-yl}piperidine-1-carboxamide; ethyl 5-{1\u2032-[(2R)-3-(7-methyl-1H-indazol-5-yl)-2-({[4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidin-1-yl]carbonyl}amino)propanoyl]-1,4\u2032-bipiperidin-4-yl}-4H-1,2,4-triazole-3-carboxylate; N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-[4-(4H-1,2,4-triazol-3-yl)-1,4\u2032-bipiperidin-1\u2032-yl]propan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide; N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(5-methyl-4H-1,2,4-triazol-3-yl)-1,4\u2032-bipiperidin-1\u2032-yl]-1-oxopropan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide; and 5-{1\u2032-[(2R)-3-(7-methyl-1H-indazol-5-yl)-2-({[4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidin-1-yl]carbonyl}amino)propanoyl]-1,4\u2032-bipiperidin-4-yl}-4H-1,2,4-triazole-3-carboxylic acid; or salt thereof or an optical isomer thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.19444
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15336893', '15588051', '15336880', '15336866', '15708424']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.829836824742599
- 35 USC 102 Novelty (BERT): 0.6327824242091711
- Combined Prediction Score: 0.8101313846892562
- Mean Citation Score: 475.208122
- Max Citation Score: 583.58514
- Similarity Product: 564.3004682685971

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test